January 20, 2023
Colleen Kraft, MD, senior medical director of clinical adoption at Cognoa, discusses how autism spectrum disorder (ASD) development affects children and families, along with how early diagnosis and treatment can improve the lives of children with ASD.
January 11, 2023
A recent study found that while children exposed to benzodiazepine during pregnancy had a greater risk of developing autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), siblings without exposure saw similar risks of neurodevelopmental disorders.
January 02, 2023
We revisit some of last year’s top articles about autism spectrum disorder.
December 19, 2022
When comparing the rate of diagnoses for autism spectrum disorder given clinically to those given through the Autism Diagnostic Observation Schedule (ADOS), consistency between the 2 methods was found.
June 13, 2022
A new study examined the effectiveness of different survey recruitment strategies when engaging parents of children with autism.
April 12, 2022
Recent research suggests females with autism may need their own set of parameters on which to be measured.
June 18, 2021
Global prevalence of autism spectrum disorder is 1% to 2%, but little research has been done in non-White populations. An investigation offers some much-needed insight.
June 02, 2021
The US Food and Drug Administration has given marketing authorization to Cognoa, Inc. for their device to aid in the diagnosis of autism spectrum disorder (ASD).
May 21, 2021
A study examines if promoting positive behaviors including masking leads to improved face covering in children with autism spectrum disorder and/or attention-deficit/hyperactivity disorder.
May 04, 2021
Is there value in predictive testing for autism spectrum disorder (ASD)? A study examines the ethics.